Clinical Validation of a Microfluidic Device for Isolation and Molecular Characterization of Circulating Tumor Cells

2014-08-26 22:17:38 | BioPortfolio


To evaluate the efficiency of a microdevice for circulating tumor cells isolation and to correlate the circulating titre with response and progression.


- Validate the clinical use of a mircofluidic device to capture circulating timor cells from a broad range of tumor types

- Characterize and identify these circulating tumor cells and demostrate cell viability with this capture method

- Apply this technology in clinically relevant settings and correlate to response to treatment and disease progression

- Elucidate predictive and pharmacodynamic biomarkers in the context of early phase trials of novel therapeutics

Study Design

Observational Model: Cohort, Time Perspective: Prospective




Blood taking


National Cancer Centre




National Cancer Centre, Singapore

Results (where available)

View Results


Published on BioPortfolio: 2014-08-26T22:17:38-0400

Clinical Trials [425 Associated Clinical Trials listed on BioPortfolio]

Ponatinib - 2nd Line Therapy

The goal of this clinical research study is to learn if ponatinib can help to control CML in chronic phase. The safety of this drug will also be studied. Ponatinib is designed to block t...

A Kidney Transplant Study to Look at the Effects of Taking Fixed Doses of CellCept Versus Taking Doses of CellCept Based on the Concentration of CellCept in the Blood When Taking Full or Reduced Dose Calcineurin Inhibitors

This research is being done to study the effects (good and bad) of taking CellCept based on blood concentrations versus taking a fixed dose of CellCept without measuring the blood concentr...

A Study to Compare Anti-HIV Drugs Given Twice a Day or Once a Day, With or Without Direct Observation

Anti-HIV drug therapy works best when the drugs are taken exactly as prescribed by a doctor. Because anti-HIV therapy often involves multiple drugs, some people have difficulty taking them...

Gene Expression Following Short Term Exposure to Neoadjuvant Endocrine Therapy in Invasive Breast Cancer

The purpose of this pilot study is to see if taking anastrozole (Arimidex) for 10 days causes changes in breast cancer cells. Anastrozole (Arimidex) is a drug used in the treatment of a ty...

Olaparib Treatment in BRCA Mutated Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy

Comparison of olaparib against a placebo in patients with ovarian cancer whose cancer has already improved by taking platinum based chemotherapy. The patients must also have a fault in the...

PubMed Articles [21516 Associated PubMed Articles listed on BioPortfolio]

Expression of MALAT1 in the peripheral whole blood of patients with lung cancer.

A blood-based biomarker assay is a non-invasive way to screen that can identify lung cancer at an earlier stage to improve the clinical outcome. MALAT1 is a broadly expressed, long non-coding RNA in h...

Blood Telomere Length Attrition and Cancer Development in the Normative Aging Study Cohort.

Accelerated telomere shortening may cause cancer via chromosomal instability, making it a potentially useful biomarker. However, publications on blood telomere length (BTL) and cancer are inconsistent...

Blood-Based Tests for Colorectal Cancer Screening: Do They Threaten the Survival of the FIT Test?

Colorectal cancer is the second leading cause of cancer death in industrialized nations, accounting for 10 % of the total cancer burden with an individual lifetime risk of ~6 % in the USA (Siegel et...

Improved SERS Nanoparticles for Direct Detection of Circulating Tumor Cells in the Blood.

The detection of circulating tumor cells (CTCs) in the blood of patients with cancer is crucial for early diagnosis of cancer, cancer prognosis, assessment of tumor sensitivity to anticancer drugs and...

In Utero Exposure to Diethylstilbestrol and Blood DNA Methylation in Women Ages 40-59 Years from the Sister Study.

In utero exposure to diethylstilbestrol (DES) has been associated with increased risk of adverse health outcomes such as fertility problems and vaginal as well as breast cancer. Animal studies have li...

Medical and Biotech [MESH] Definitions

The taking of a blood sample to determine its character as a whole, to identify levels of its component cells, chemicals, gases, or other constituents, to perform pathological examination, etc.

Skills and strategies, unrelated to the traits a test is intended to measure, that may increase test takers' scores -- may include the effects of coaching or experience in taking tests. (ERIC Thesaurus)

A cancer registry mandated under the National Cancer Act of 1971 to operate and maintain a population-based cancer reporting system, reporting periodically estimates of cancer incidence and mortality in the United States. The Surveillance, Epidemiology, and End Results (SEER) Program is a continuing project of the National Cancer Institute of the National Institutes of Health. Among its goals, in addition to assembling and reporting cancer statistics, are the monitoring of annual cancer incident trends and the promoting of studies designed to identify factors amenable to cancer control interventions. (From National Cancer Institute, NIH Publication No. 91-3074, October 1990)

Unlawful act of taking property.

More From BioPortfolio on "Clinical Validation of a Microfluidic Device for Isolation and Molecular Characterization of Circulating Tumor Cells"


Relevant Topics

Cancer Disease
Latest News Clinical Trials Research Drugs Reports Corporate
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Latest News Clinical Trials Research Drugs Reports Corporate
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Searches Linking to this Trial